Redeye: Net Insight - Continued investments burdened the quarter

Net Insights report was acceptable on revenues (although lower than estimates) but high opex, driven by increased sales resources and increased resources allocated to the commercialization of Sye burdened the quarter. Following the report, we have cut our short-term estimates due to higher opex and lower sales. All in all, we arrive at a slightly lower valuation. The most important metric for Net Insight concerns top-line growth, this is where our emphasis will be going forward. There is no doubt that there are great scalability in the products and business model, and thus profitability will follow if sales accelerate

Read more and download the research report: http://bit.ly/2OAQZdX

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/